Traditional Chinese Medicine Research Experimental Data Analysis Services

Traditional Chinese Medicine (TCM) research experimental data analysis services provide professional statistical processing, bioinformatics interpretation, and multi-omics data integration for academic and industrial research on herbal medicines. Our comprehensive analysis platform supports pharmacological studies, quality control research, network pharmacology, and clinical trial evaluation, transforming raw experimental data into publication-ready results. With rigorous statistical methodologies and domain-specific expertise, we help researchers accelerate TCM modernization and evidence-based validation.

Technical Overview

Traditional Chinese Medicine (TCM) research experimental data analysis services deliver end-to-end computational and statistical support for investigations involving herbal formulations, natural compounds, and integrative medicine approaches. Modern TCM research generates heterogeneous datasets spanning chromatographic fingerprinting, pharmacokinetic profiles, transcriptomic and metabolomic measurements, and clinical outcome variables. Converting these raw datasets into scientifically defensible conclusions requires specialized analytical pipelines that respect both the complexity of multi-component herbal systems and the standards of contemporary biomedical publication.

Our analysis services cover the complete research data lifecycle, including experimental design consultation, data cleaning and normalization, statistical hypothesis testing, multivariate pattern recognition, pathway enrichment analysis, and graphical visualization. Every analytical workflow is documented with version-controlled scripts and reproducible reports, ensuring that results satisfy the methodological transparency requirements of peer-reviewed journals, regulatory submissions, and graduate thesis committees.

Analyses are performed by an interdisciplinary team combining biostatisticians, bioinformaticians, and pharmacologists with hands-on experience in TCM modernization research. This ensures that statistical decisions—such as handling multi-herb interactions, batch effects in botanical sourcing, or dose-response modeling of compound mixtures—are biologically informed rather than purely mechanical.

Testing Samples

Herbal Extract and Decoction Datasets

Quantitative data derived from aqueous and ethanol extracts, including HPLC and UPLC-MS/MS peak tables, multi-component quantification results, and extraction yield measurements across batches, solvent systems, and processing conditions.

Pharmacological Experiment Data

In vivo and in vitro efficacy datasets such as animal behavioral scores, organ index measurements, ELISA cytokine readings, cell viability assays (MTT, CCK-8), and dose-response curves from herbal intervention studies.

Omics Datasets

High-throughput data from transcriptomics (RNA-seq), proteomics (LC-MS/MS), and metabolomics platforms, including raw sequencing reads, spectral feature tables, and gas chromatography-mass spectrometry (GC-MS) metabolic profiles from serum, urine, and tissue samples.

Network Pharmacology Input Data

Compound-target databases, protein-protein interaction networks, disease gene sets, and molecular docking score matrices used to construct herb-compound-target-pathway models.

Clinical and Preclinical Trial Data

Randomized controlled trial records, symptom scoring scales, safety laboratory values, and longitudinal follow-up measurements from human studies and animal efficacy experiments.

Quality Control Data

Fingerprint similarity matrices, heavy metal and pesticide residue measurements, and stability testing results from herbal material standardization studies.

Testing Items

Our service catalog includes the following core analytical items:

• Descriptive statistics and distribution assessment for all experimental groups
• Parameteric and non-parametric hypothesis testing (t-test, ANOVA, Mann-Whitney U, Kruskal-Wallis) with post-hoc multiple comparison correction
• Correlation and regression analysis, including dose-response and time-course modeling
• Survival analysis and longitudinal data analysis for animal and clinical studies
• Multivariate statistical analysis: principal component analysis (PCA), partial least squares discriminant analysis (PLS-DA), orthogonal PLS-DA, and hierarchical clustering
• Chromatographic fingerprint similarity evaluation and common peak assignment
• Pharmacokinetic parameter estimation (Cmax, Tmax, AUC, t1/2, clearance) via non-compartmental and compartmental modeling
• Network pharmacology construction: compound-target networks, GO and KEGG pathway enrichment, and molecular docking result integration
• Metabolomic biomarker screening with variable importance in projection (VIP) scoring and receiver operating characteristic (ROC) validation
• Differentially expressed gene and protein identification with fold-change and false discovery rate (FDR) control
• Sample size calculation and statistical power analysis for study planning
• Publication-grade figure preparation and statistical reporting in compliance with journal guidelines

Testing Methods

Statistical Analysis Framework

All statistical procedures follow predefined analysis plans consistent with ICH E9 principles and ARRIVE reporting guidelines. Data normality is verified using Shapiro-Wilk tests and visual diagnostics, homogeneity of variance with Levene's test, and appropriate transformations are applied before parametric testing. Multiple comparisons are controlled using Tukey, Bonferroni, or Benjamini-Hochberg procedures depending on the study context. Analyses are executed in R, SPSS, or SAS, with significance conventionally set at a two-sided alpha of 0.05.

Chemometric and Multivariate Methods

Metabolomic and fingerprint datasets are processed through established chemometric workflows using SIMCA-P and R packages such as ropls and mixOmics. Unsupervised PCA models assess intrinsic clustering and outlier presence, while supervised PLS-DA and OPLS-DA models discriminate experimental groups. Model validity is confirmed through permutation testing (typically 200 iterations) and cross-validated Q2 metrics to guard against overfitting.

Bioinformatics Pipelines

Transcriptomic data are processed through FastQC quality control, alignment via HISAT2 or STAR, quantification with featureCounts or Salmon, and differential expression analysis using DESeq2 or edgeR. Functional enrichment is performed against Gene Ontology and KEGG databases with clusterProfiler. Proteomic workflows employ MaxQuant or Proteome Discoverer with label-free quantification and subsequent pathway mapping.

Network Pharmacology Methodology

Active compounds are filtered by oral bioavailability and drug-likeness thresholds using TCMSP, BATMAN-TCM, or HERB databases. Compound targets are mapped against disease gene sets from GeneCards and OMIM, and networks are constructed and topologically analyzed in Cytoscape, with hub gene identification through degree, betweenness, and closeness centrality metrics.

Data Integrity and Reproducibility

Every project maintains complete audit trails including raw data, processing scripts, software versions, and parameter settings. Statistical code is preserved in scripted formats (R Markdown or Jupyter notebooks) so that clients and reviewers can reproduce every figure and table independently.

Applications

Academic Research and Dissertation Support

Graduate students and faculty researchers rely on these services for thesis experiments, national natural science foundation projects, and publication in SCI-indexed journals, where rigorous statistics and reproducible omics analysis are decisive factors in peer review.

Herbal Formula Mechanism Elucidation

Network pharmacology combined with metabolomic validation reveals the multi-target, multi-pathway mechanisms of classical formulas, supporting mechanistic papers on anti-inflammatory, antioxidant, hepatoprotective, and neuroprotective herbal actions.

Quality Standardization and Consistency Evaluation

Manufacturers and research institutes apply fingerprint similarity analysis and multivariate batch classification to standardize herbal materials, evaluate processing variations, and establish stable quality benchmarks for formulation development.

Pharmacokinetic and Bioavailability Studies

Compounds from herbal extracts are profiled for absorption, distribution, and elimination characteristics, informing dosage form optimization, compatibility rationales, and herb-drug interaction assessments.

Preclinical and Clinical Evidence Generation

Efficacy data from animal models and human trials are analyzed to support evidence-based claims, regulatory dossiers, and systematic review meta-analyses that advance TCM integration into mainstream therapeutic guidelines.

Biomarker Discovery and Precision Medicine Research

Metabolomic and transcriptomic screening identifies response biomarkers that stratify patient populations, laying groundwork for personalized herbal medicine applications.

FAQ

What file formats can I submit for analysis?

We accept raw instrument outputs (AB SCIEX, Waters, Thermo formats), exported CSV and Excel tables, sequencing FASTQ files, and image-derived quantification data. Project managers will confirm format compatibility before project initiation and assist with data structuring if needed.

How long does a typical analysis project take?

Standard statistical analysis of pre-organized datasets is generally completed within 3 to 5 working days. Network pharmacology studies typically require 5 to 10 working days, while full multi-omics integration projects may extend to 2 to 4 weeks depending on data volume and revision rounds.

Can you help if my experimental design is still in the planning stage?

Yes. Pre-project consultation covers group allocation, sample size calculation, randomization strategy, and endpoint selection so that the eventual data structure supports valid statistical inference and avoids common design flaws that cannot be corrected after data collection.

Do you provide interpretation support along with the statistical results?

All deliverables include a written interpretation section explaining the biological meaning of statistical findings, limitations of the analysis, and suggested discussion points for manuscripts, ensuring that numerical outputs are translated into scientific narrative.

Is my research data kept confidential?

A non-disclosure agreement is executed before any data transfer. All files are stored on access-controlled servers, used solely for the commissioned analysis, and permanently deleted or returned upon client request after project completion.

What software do you use, and can I request a specific platform?

Our default platforms include R, GraphPad Prism, SPSS, SIMCA-P, Cytoscape, and Python-based pipelines. Clients may specify preferred software to meet journal requirements or institutional standards, and we will adapt the workflow accordingly.